Showing 1 - 12 results of 12 for search 'Vaňásek, T', query time: 0.04s
Refine Results
-
1
-
2
Previous Lumbar Spine Surgery Decreases the Therapeutic Efficacy of Dorsal Root Ganglion Pulsed Radiofrequency in Patients with Chronic Lumbosacral Radicular Pain by Jiri Jandura, Milan Vajda, Roman Kostysyn, Jiri Vanasek, Eva Cermakova, Jan Zizka, Pavel Ryska
Published 2023-06-01
Article -
3
-
4
-
5
-
6
-
7
Protect-1, a prospective randomized oral therapy evaluation of CCX282-B (Traficet-EN) in Crohn's disease trial by Bekker, P, Petryka, R, Vanasek, T, Niv, Y, Marlicz, K, Haagen-Nielsen, O, Dahelrup, J, Dotan, I, Compel, V, Keshav, S, Schall, T
Published 2008Conference item -
8
Tight control for Crohn's disease with adalimumab-based treatment is cost-effective: an economic assessment of the CALM trial by Panaccione, R, Colombel, J, Travis, S, Bossuyt, P, Baert, F, Vaňásek, T, Danalıoğlu, A, Novacek, G, Armuzzi, A, Reinisch, W, Johnson, S, Buessing, M, Neimark, E, Petersson, J, Lee, W, D'Haens, G
Published 2019Journal article -
9
A randomized controlled trial of the efficacy and safety of CCX282-B, an orally-administered blocker of chemokine receptor CCR9, for patients with Crohn's disease. by Satish Keshav, Tomáš Vaňásek, Yaron Niv, Robert Petryka, Stephanie Howaldt, Mauro Bafutto, István Rácz, David Hetzel, Ole Haagen Nielsen, Séverine Vermeire, Walter Reinisch, Per Karlén, Stefan Schreiber, Thomas J Schall, Pirow Bekker, Prospective Randomized Oral-Therapy Evaluation in Crohn’s Disease Trial-1 PROTECT-1 Study Group
Published 2013-01-01
Article -
10
Autologous dendritic cell-based immunotherapy (DCVAC/LuCa) and carboplatin/paclitaxel in advanced non-small cell lung cancer: A randomized, open-label, phase I/II trial by Milada Zemanova, Marketa Cernovska, Libor Havel, Tomas Bartek, Sarka Lukesova, Jitka Jakesova, Jaroslav Vanasek, Pavel Reiterer, Juraj Kultan, Igor Andrasina, Lenka Siskova, Leona Koubkova, Jana Skrickova, Frantisek Salajka, Milos Pesek, Petr Klepetko, Juraj Beniak, Harald Fricke, Pavla Kadlecova, Roman P. Korolkiewicz, Marek Hraska, Jirina Bartunkova, Radek Spisek
Published 2021-01-01
Article -
11
Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial. by Colombel, J, Panaccione, R, Bossuyt, P, Lukas, M, Baert, F, Vanasek, T, Danalioglu, A, Novacek, G, Armuzzi, A, Hébuterne, X, Travis, S, Danese, S, Reinisch, W, Sandborn, W, Rutgeerts, P, Hommes, D, Schreiber, S, Neimark, E, Huang, B, Zhou, Q, Mendez, P, Petersson, J, Wallace, K, Robinson, A, Thakkar, R, D'Haens, G
Published 2017Journal article -
12
Endoscopic and deep remission at 1 year prevents disease progression in early Crohn’s disease: long-term data from CALM by Yzet, C, Ungaro, R, Bossuyt, P, Baert, F, Vanasek, T, D'Haens, G, Joustra, V, Panaccione, R, Novacek, G, Armuzzi, A, Golovchenko, O, Prymak, O, Goldis, A, Travis, S, Hebuterne, X, Ferrante, M, Rogler, G, Fumery, M, Danese, S, Rydzewska, G, Pariente, B, Hertervig, E, Stanciu, C, Grimaud, J, Diculescu, M, Peyrin-Biroulet, L, Laharie, D, Wright, J, Gomollon, F, Gubonina, I, Schreiber, S, Motoya, S, Hellstrom, P, Halfvarson, J, Colombel, J
Published 2019Conference item